Cargando…
Alkylating anticancer agents and their relations to microRNAs
Alkylating agents represent an important class of anticancer drugs. The occurrence and emergence of tumor resistance to the treatment with alkylating agents denotes a severe problem in the clinics. A detailed understanding of the mechanisms of activity of alkylating drugs is essential in order to ov...
Autor principal: | Biersack, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019174/ https://www.ncbi.nlm.nih.gov/pubmed/35582140 http://dx.doi.org/10.20517/cdr.2019.09 |
Ejemplares similares
-
Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs
por: Biersack, Bernhard
Publicado: (2016) -
3,3’-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAs
por: Biersack, Bernhard
Publicado: (2020) -
Synthetic Small Molecule Modulators of Hsp70 and Hsp40 Chaperones as Promising Anticancer Agents
por: Nitzsche, Bianca, et al.
Publicado: (2023) -
microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance
por: Monchusi, Bernice, et al.
Publicado: (2020) -
MicroRNAs in age-related diseases
por: Dimmeler, Stefanie, et al.
Publicado: (2013)